BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25996047)

  • 21. Applicability of tumor spheroids for
    Hamilton G; Rath B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):15-23. PubMed ID: 30484335
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids.
    Herrmann R; Fayad W; Schwarz S; Berndtsson M; Linder S
    J Biomol Screen; 2008 Jan; 13(1):1-8. PubMed ID: 18040052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
    LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB
    Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?
    Friedrich J; Ebner R; Kunz-Schughart LA
    Int J Radiat Biol; 2007; 83(11-12):849-71. PubMed ID: 18058370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
    Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
    SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LA-ICP-MS imaging in multicellular tumor spheroids - a novel tool in the preclinical development of metal-based anticancer drugs.
    Theiner S; Schreiber-Brynzak E; Jakupec MA; Galanski M; Koellensperger G; Keppler BK
    Metallomics; 2016 Apr; 8(4):398-402. PubMed ID: 26806253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Media additives to promote spheroid circularity and compactness in hanging drop platform.
    Leung BM; Lesher-Perez SC; Matsuoka T; Moraes C; Takayama S
    Biomater Sci; 2015 Feb; 3(2):336-44. PubMed ID: 26218124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
    Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
    SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
    Mukundan S; Bell J; Teryek M; Hernandez C; Love AC; Parekkadan B; Chan LL
    J Fluoresc; 2022 Mar; 32(2):521-531. PubMed ID: 34989923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
    Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
    Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicellular tumor spheroids: an underestimated tool is catching up again.
    Hirschhaeuser F; Menne H; Dittfeld C; West J; Mueller-Klieser W; Kunz-Schughart LA
    J Biotechnol; 2010 Jul; 148(1):3-15. PubMed ID: 20097238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
    Howes AL; Richardson RD; Finlay D; Vuori K
    PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the spheroid model complexity on drug response.
    Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
    J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics.
    Solomon MA; Lemera J; D'Souza GG
    J Liposome Res; 2016 Sep; 26(3):246-60. PubMed ID: 26780923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
    Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
    Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
    Karlsson H; Fryknäs M; Larsson R; Nygren P
    Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microarray Embedding/Sectioning for Parallel Analysis of 3D Cell Spheroids.
    Gabriel J; Brennan D; Elisseeff JH; Beachley V
    Sci Rep; 2019 Nov; 9(1):16287. PubMed ID: 31705048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing.
    Lama R; Zhang L; Naim JM; Williams J; Zhou A; Su B
    Bioorg Med Chem; 2013 Feb; 21(4):922-31. PubMed ID: 23306053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spheroids Formation on Non-Adhesive Surfaces by Liquid Overlay Technique: Considerations and Practical Approaches.
    Costa EC; de Melo-Diogo D; Moreira AF; Carvalho MP; Correia IJ
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 29058365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 3D biomimetic model of tissue stiffness interface for cancer drug testing.
    Lam CR; Wong HK; Nai S; Chua CK; Tan NS; Tan LP
    Mol Pharm; 2014 Jul; 11(7):2016-21. PubMed ID: 24754837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.